FPF
JAZZ icon

FNY Partners Fund’s Jazz Pharmaceuticals JAZZ Stock Holding History

FNY Partners Fund’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-600
Closed -$87K – 514
2017
Q3 		$87K Buy
+600
New +$90.7K 0.01% 244
2017
Q2 		– Sell
-200
Closed -$29K – 849
2017
Q1 		$29K Buy
+200
New +$26K ﹤0.01% 862

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

FNY Partners Fund's JAZZ Position: Q4 2017 in Review

FNY Partners Fund sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2017, closing a stake of 600 shares — an estimated $87K sold.

FNY Partners Fund first reported a position in JAZZ in Q1 2017 and held it in 2 quarters. The position peaked at $87K in Q3 2017. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

  • FNY Partners Fund reported no remaining Jazz Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • FNY Partners Fund sold 600 Jazz Pharmaceuticals shares in Q4 2017, an estimated $87K.
  • FNY Partners Fund first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Jazz Pharmaceuticals position peaked at $87K in Q3 2017.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.